Clinical Trials in Australian Public Health Institutions 2018-19 (NAS 4 report)

This report is the Framework for National Aggregate Statistics (NAS) and annual collection of data by all jurisdictions through the Clinical Trials Project Reference Group (CTPRG).

Downloads

Clinical Trials in Australian Public Health Institutions 2018-19 (NAS 4 report)

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Publication type:
Report
Audience:
Health sector
Language:
English
Description:

This Fourth National Aggregate Statistics Report on Clinical Trials in Australia (NAS 4 Report) was produced by Victoria on behalf of all jurisdictions, through the Clinical Trials Project Reference Group (CTPRG).

For the first time this iteration includes data from all 8 jurisdictions.

The NAS 4 Report represent new clinical trials in 2018-19 in public health organisation from 8 jurisdictions. Key findings indicated that in public health organisations in Australia:

  • A total of 940 clinical new clinical trials were reported in the period
  • The majority of clinical trials were multi-site, Phase 3 and commercially sponsored
  • The number of Phase 1 trails increased significantly since 2016-17 and there was an increase in the number of trials sponsored by the Investigator Initiated Group
  • There was a slight reduction in the number of clinical trials approved within the benchmark of 60 days, however the majority completed the process within 120 days and
  • The administrative process for most Site Specific Assessment applications is completed within 60 days.

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.